Published in J Biol Chem on May 25, 1987
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest (1988) 4.76
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med (1992) 3.37
Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J (1995) 2.87
Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol (1988) 2.66
Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol (1994) 1.83
Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol (2007) 1.80
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J Clin Invest (2002) 1.67
Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest (1990) 1.67
Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc Natl Acad Sci U S A (1990) 1.30
TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci (2005) 1.30
Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med (1989) 1.24
Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect (1997) 1.18
The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med (1996) 1.16
Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis. EMBO J (1991) 1.15
RNA processing is a limiting step for murine tumor necrosis factor beta expression in response to interleukin-2. Mol Cell Biol (1990) 1.10
Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog Neurobiol (2007) 1.09
Increased hippocampal uptake of tumor necrosis factor alpha and behavioral changes in mice. Exp Brain Res (2003) 1.06
Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels. Biochem J (1992) 1.05
Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol (1998) 1.05
Tumour necrosis factor: a cytokine with multiple biological activities. Br J Cancer (1990) 1.04
Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha. Infect Immun (1987) 1.02
Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest (1994) 1.01
Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut (2002) 1.00
Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma. PLoS Comput Biol (2010) 1.00
Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J Virol (2005) 0.92
Cytokine receptors: structure and signal transduction. Clin Exp Immunol (1992) 0.89
Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. Proc Natl Acad Sci U S A (1993) 0.87
Structural insights into the C1q domain of Caprin-2 in canonical Wnt signaling. J Biol Chem (2014) 0.86
Competitive adsorption of thiolated polyethylene glycol and mercaptopropionic acid on gold nanoparticles measured by physical characterization methods. Langmuir (2010) 0.84
Recognition of human tumor necrosis factor α (TNF-α) by therapeutic antibody fragment: energetics and structural features. J Biol Chem (2012) 0.84
Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts. J Biol Chem (2012) 0.82
New binding mode to TNF-alpha revealed by ubiquitin-based artificial binding protein. PLoS One (2012) 0.80
Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity. Clin Exp Immunol (2003) 0.80
Automated Analysis of Single-Molecule Photobleaching Data by Statistical Modeling of Spot Populations. Biophys J (2015) 0.78
Lysine fatty acylation promotes lysosomal targeting of TNF-α. Sci Rep (2016) 0.77
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice. Antimicrob Agents Chemother (1999) 0.76
Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells. Mol Clin Oncol (2015) 0.76
Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function. J Transl Med (2015) 0.76
SOCS3 dictates the transition of divergent time-phased events in granulocyte TNF-α signaling. Cell Mol Immunol (2013) 0.76
Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure. Arch Biochem Biophys (2013) 0.75
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters. Arch Immunol Ther Exp (Warsz) (2007) 0.75
Biological activity of mutants of human tumour necrosis factor-alpha. Immunology (1992) 0.75
Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2. Sci Rep (2017) 0.75
Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer (2001) 6.16
Overlapping genes at the cheA locus of Escherichia coli. Proc Natl Acad Sci U S A (1980) 4.82
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet (2000) 3.76
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer (1995) 3.32
Interferon-induced enzymatic activities and their role in the antriviral state. Cell (1979) 3.22
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
Inhibition of initiation of protein synthesis by 7-methylguanosine-5'-monophosphate. Proc Natl Acad Sci U S A (1976) 3.14
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem (2000) 3.12
Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF. EMBO J (1993) 3.11
American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin (1997) 2.89
Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem (1987) 2.74
Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J (1995) 2.73
Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature (1981) 2.71
Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A. Nature (1978) 2.59
Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med (2001) 2.47
Evidence that types I and II interferons have different receptors. Nature (1981) 2.44
Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem (1979) 2.43
Increasing physician productivity and the hospitalization characteristics of practices using Medex. A progress report. Northwest Med (1971) 2.34
Inhibition of protein synthesis in reticulocytes by antibiotics. I. Effects on polysomes. Biochim Biophys Acta (1966) 2.31
Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer (2003) 2.26
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology (2004) 2.26
The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun (1979) 2.26
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr (1997) 2.24
Probing proton dynamics in molecules on an attosecond time scale. Science (2006) 2.24
Lymphedema: current issues in research and management. CA Cancer J Clin (2000) 2.21
Reiteration frequency of haemoglobin genes in the duck. Nat New Biol (1972) 2.20
Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem (1985) 2.18
Further evidence of transcriptional and translational control of histone messenger RNA during the HeLa S3 cycle. Cell (1975) 2.16
Pressure support ventilation decreases inspiratory work of breathing during general anesthesia and spontaneous ventilation. Anesth Analg (1992) 2.14
Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer (1995) 2.13
Inhibition of protein synthesis in reticulocytes by antibiotics. II. The site of action of cycloheximide, streptovitacin A and pactamycin. Biochim Biophys Acta (1966) 2.12
Evidence for role of m7G5'-phosphate group in recognition of eukaryotic mRNA by initiation factor IF-M3. Nature (1976) 2.09
Allelic antigenic factor Inv(a) of the light chains of human immunoglobulins: chemical basis. Science (1966) 2.03
Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol (1986) 2.00
Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens. Infect Immun (1972) 1.99
A study guided by the Health Belief Model of the predictors of breast cancer screening of women ages 40 and older. Public Health Rep (1991) 1.97
Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med (1987) 1.95
Inhibition of mRNA binding to ribosomes by localized activation of dsRNA-dependent protein kinase. Nature (1984) 1.91
Determination of inorganic phosphate in the presence of labile organic phosphates. Anal Biochem (1969) 1.89
The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med (1991) 1.84
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res (1996) 1.84
Planning for the future: the experience of implementing a children's day assessment unit in a district general hospital. Arch Dis Child (1997) 1.83
Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev (2000) 1.82
The pressure reversal of general anesthesia and the critical volume hypothesis. Mol Pharmacol (1973) 1.79
Synthesis of (2'-5')oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J Virol (1982) 1.77
Mechanisms of antiviral action of interferon. Interferon (1983) 1.76
Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin (1997) 1.75
Intranasal Teeth. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol (1979) 1.73
Pre- and postnatal choline supplementation produces long-term facilitation of spatial memory. Dev Psychobiol (1988) 1.72
Comparing the quality of death for hospice and non-hospice cancer patients. Med Care (1988) 1.67
Hemodynamic and gas exchange alterations during Intralipid infusion in patients with adult respiratory distress syndrome. Chest (1989) 1.66
Detection of delayed hypersensitivity in mice injected with ribonucleic acid-protein fractions of Salmonella typhimurium. Infect Immun (1972) 1.64
Methionine synthesis from 5'-methylthioadenosine in rat liver. J Biol Chem (1981) 1.63
Expression of calf prochymosin in Saccharomyces cerevisiae. Gene (1984) 1.61
Heterologous protein secretion from yeast. Science (1985) 1.58
Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci U S A (1979) 1.57
Retracted Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections. Proc Natl Acad Sci U S A (1987) 1.57
Absence of messenger RNA for beta globin chain in beta(0) thalassaemia. Nature (1974) 1.55
Expression cloning and signaling properties of the rat glucagon receptor. Science (1993) 1.54
Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology (1972) 1.53
Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J Biol Chem (1988) 1.52
Messenger RNA for globin in the postribosomal supernatant of rabbit reticulocytes. Proc Natl Acad Sci U S A (1972) 1.51
Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer (1989) 1.51
Cystic ameloblastoma--behavior and treatment of 21 cases. J Oral Maxillofac Surg (2001) 1.51
Phosphorylation of initiation factor eIF-2 alpha, binding of mRNA to 48 S complexes, and its reutilization in initiation of protein synthesis. J Biol Chem (1983) 1.50
Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis (1990) 1.50
Techniques in the detection and characterization of phosphoramidate-containing proteins. Methods Enzymol (1984) 1.50
Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells. J Biol Chem (1979) 1.49
Escherichia coli O157 in feedlot cattle feces and water in four major feeder-cattle states in the USA. Prev Vet Med (2003) 1.49
American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin (1997) 1.48
The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci U S A (1974) 1.48
Regulation of haemoglobin synthesis at the polysome level. J Mol Biol (1966) 1.47
Interaction of interferon with cellular receptors. Internalization and degradation of cell-bound interferon. J Biol Chem (1982) 1.46
Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res (1992) 1.45
NMR analysis of main-chain conformational preferences in an unfolded fibronectin-binding protein. J Mol Biol (1997) 1.45
Inhibition of protein synthesis by Cl-. J Biol Chem (1977) 1.44
Inhibition of protein synthesis in reovirus-infected HeLa cells with elevated levels of interferon-induced protein kinase activity. J Biol Chem (1982) 1.44
A simple and fast method to extract RNA from tissue culture cells. Biotechniques (1990) 1.43
Direct demonstration of retroviral recombination in a rhesus monkey. J Virol (1997) 1.41
Intermittent CPAP: a new mode of ventilation during general anesthesia. Anesthesiology (1998) 1.41
Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. J Biol Chem (1986) 1.40
Development and verification of a schistosomiasis transmission model. Am J Trop Med Hyg (1977) 1.39
The roles of patient and observer assessments in anti-emetic trials. Eur J Cancer (1994) 1.39
Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both. Behav Neurosci (1989) 1.38
Saskatchewan. Acute mustard seed toxicosis in beef cattle. Can Vet J (1989) 1.37
Canine ventricular arrhythmias in the late myocardial infarction period. 8. Epicardial mapping of reentrant circuits. Circ Res (1981) 1.36
5'-Terminal 7-methylguanosine and mRNA function: influence of potassium concentration on translation in vitro. Proc Natl Acad Sci U S A (1977) 1.35
A self report measure of affective lability. J Neurol Neurosurg Psychiatry (1997) 1.35
Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. Proc Natl Acad Sci U S A (1992) 1.34
Inhibition of HeLa cell messenger RNA translation by 7-methylguanosine 5'-monophosphate. J Biol Chem (1976) 1.32
Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen (2004) 1.31
Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem (1991) 1.31
Mechanisms of action of human interferons. Induction of 2'5'-oligo(A) polymerase. J Biol Chem (1980) 1.31
Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J (2008) 1.31
A relation between inhibition of protein synthesis and conformation of 5'-phosphorylated 7-methylguanosine derivatives. J Mol Biol (1977) 1.31
Maxillary sinus complications related to endosseous implants. Int J Oral Maxillofac Implants (1995) 1.30
The mammography audit: a primer for the mammography quality standards act (MQSA). AJR Am J Roentgenol (1995) 1.29